Innoviva Number of Employees 2010-2024 | INVA
Innoviva number of employees from 2010 to 2024. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Innoviva Annual Employee Count |
| 2024 |
127 |
| 2023 |
112 |
| 2022 |
101 |
| 2021 |
5 |
| 2020 |
5 |
| 2019 |
6 |
| 2018 |
6 |
| 2017 |
12 |
| 2016 |
14 |
| 2015 |
13 |
| 2014 |
10 |
| 2013 |
241 |
| 2012 |
226 |
| 2011 |
222 |
| 2010 |
193 |
| 2009 |
194 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$1.145B |
$0.359B |
|
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
|
